• Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

SEB Concept Biotechnology

+ Add to Watchlist

BFGCBIO:LX

87.87 EUR 0.92 1.04%

As of 00:59:30 ET on 09/15/2014.

Snapshot for SEB Concept Biotechnology (BFGCBIO)

Year To Date: +28.01% 3-Month: +15.05% 3-Year: +40.27% 52-Week Range: 59.49 - 90.24
1-Month: +6.64% 1-Year: +38.79% 5-Year: +29.79% Beta vs LUXXX: 0.65

Mutual Fund Chart for BFGCBIO

No chart data available.
  • BFGCBIO:LX 87.87
  • 1M
  • 1Y
Interactive BFGCBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BFGCBIO

SEB Concept Biotechnology is an open-end investment fund incorporated in Luxembourg. The Fund's objective is to achieve long-term capital appreciation. The Fund invests globally in equities and equity-related securities of issuers from the biotechnology sector.

Inception Date: 10-16-2000 Telephone: 352-2-66-82-1 Tel
Managers: ULRIKA BERGMAN
Web Site: www.sebgroup.lu

Fundamentals for BFGCBIO

NAV (on 2014-09-15) 87.87
Assets (M) (on 2014-09-15) 361.80
Fund Leveraged N
Minimum Investment 50.00
Minimum Subsequent Investment -

Dividends for BFGCBIO

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-01-16) 0.08
Dividend Yield (ttm) 0.09

Fees & Expenses for BFGCBIO

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.80

Top Fund Holdings for BFGCBIO

Filing Date: 06/30/2014
Name Position Value % of Total
Celgene Corp 378,298 23,728,940 9.188%
Amgen Inc 262,904 22,729,564 8.801%
Gilead Sciences Inc 309,444 18,738,777 7.255%
Biogen Idec Inc 68,115 15,686,743 6.074%
Alexion Pharmaceuticals Inc 112,194 12,803,890 4.958%
Mylan Inc/PA 305,949 11,521,638 4.461%
Endo International PLC 185,400 9,481,654 3.671%
Shire PLC 53,541 9,208,973 3.566%
Jazz Pharmaceuticals PLC 78,700 8,450,334 3.272%
Salix Pharmaceuticals Ltd 91,092 8,206,759 3.178%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil